CASP9 and colorectal cancer: Combined ABT-737/AZ’1569 treatment resulted also in potent increases in apoptosis as indicated by increased PARP cleavage and caspase-9/8/3 processing in all KRASG12CMT colorectal cancer cells (Fig. 4C; Supplementary Fig. S4F).